InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-22.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Mallick Parag, 管理人员. Officer active across 1 company, notably Nautilus Biotechnology, Inc.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 21 December 2021. The latest transaction was filed on 8 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mallick Parag
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
12,000 股@ US$0.7323100.0% 占其流量Common StockSEC:0001808805-25-000049:0
标准退出：2025年8月6日 (T+90)
210,000 股0Common StockSEC:0001808805-21-000031:0
2 条申报中的 2 条
About Mallick Parag
Mallick Parag holds an Executive position at Nautilus Biotechnology, Inc. In this role, he contributes to the strategic management of the company and the optimization of operations. His expertise in the biotechnology sector is an asset in achieving growth objectives and enhancing the customer experience. Mallick Parag plays a key role in developing the company's initiatives.
